| |
2006 Centralized Patient Monitoring Technology Global Excellence of the Year Award
Award Recipient: Cardiopulmonary
July 12, 2006
Frost & Sullivan is proud to recognize Cardiopulmonary Corporation with the 2006 Global Excellence of the Year Award in centralized patient monitoring technology for the company's cutting-edge safety applications and continued developments in centralized monitoring.
Focused on the Central Station and the Future of Centralized Patient Care, Cardiopulmonary is a visionary company – its small size belies its importance for the future of healthcare. Remarkable for a company of its size, Cardiopulmonary developed central monitoring solutions despite not having bedside devices, creating a superbly tight focus on the central station, data stream management, and alarm notification.
Cardiopulmonary as a company conceptualizes the future of patient monitoring as being intimately linked to the future of the central station; vital signs monitors already use best-in-class technologies for pulse oximetry, blood pressure monitoring, and a host of other critical data parameters. Properly understood, real innovation today is taking place at the central infrastructure level, and not necessarily at the monitoring device level.
Cardiopulmonary has focused on creating easily scalable solutions by being able to interface with any vendor device, placing a premium on the flexibility that is absolutely required for the modern hospital.
For a Best in Class Future
This company has kept its finger on the pulse of the crucial paradigm shift from legacy patient monitoring systems to best-in-class devices that has taken place due to the convergence of ventilation monitoring, infusion pump monitoring, and core patient monitoring. Cardiopulmonary continues to demonstrate its dedication to innovation in information technologies and how these will impact the future of centralized monitoring. Moreover, because patient safety concerns are driving cooperation, companies such as Cardiopulmonary are well poised to take advantage of these new trends.
Expanding from a High Value Niche
Cardiopulmonary’s Bernoulli product is a core component of the new vision. It provides monitoring ventilation to alarm if ventilation fails, alerting a very high-risk situation requiring a response within minutes at the risk of patient death. Few companies can deliver such mission-critical levels of service reliably and with a high level of quality. Undoubtedly, this will provide Cardiopulmonary with a solid base to expand to infusion pump monitoring and outward into specialty and niche applications such as standalone pulse oximetry. In summary, Cardiopulmany has developed its strengths where a number of other companies have not focused. Clearly, Cardiopulmonary is not just an integration company; Cardiopulmonary can work with other integration companies, but can also provide it’s own best-in-class integration services. In both cases, Cardiopulmonary has the in-house expertise it takes to meet customer needs.
About Best Practices
Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.
About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit www.frost.com.
|